Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provide clinical contract research organization services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment engages in the design, production, breeding, and sale of research models, including non-human primates and rodents. The company also offers cell-based assay (CBA) services. In addition, it offers drug quality research and testing services for protein drugs, vaccines, gene and cell therapy products, and provides customized solutions for early-stage drug discovery, screening, and mechanism research. Joinn Laboratories(China)Co.,Ltd. was incorporated in 1995 and is headquartered in Beijing, China.
Frequently asked questions
What sector does Joinn Laboratories China Co Ltd (6127) operate in?
Joinn Laboratories China Co Ltd belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is Joinn Laboratories China Co Ltd (6127) current stock price?
As of the latest data, Joinn Laboratories China Co Ltd stock price is HK$21.20, with a previous close of HK$21.84. Joinn Laboratories China Co Ltd lost -HK$0.64 in the last trading session, representing a -2.93% loss.
What is Joinn Laboratories China Co Ltd (6127) current market capitalization?
Joinn Laboratories China Co Ltd market cap is approximately 2.52 billion.
What is Joinn Laboratories China Co Ltd (6127) Earnings Per Share (EPS)?
The trailing EPS is HK$1.45, and the forward EPS is HK$0.55.
What is Joinn Laboratories China Co Ltd (6127) Price-to-Earnings (P/E) ratio?
Joinn Laboratories China Co Ltd current P/E ratio is 14.65, with a forward P/E of 38.81.
What is Joinn Laboratories China Co Ltd (6127) EBITDA?
Joinn Laboratories China Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 26.81 million.
Does Joinn Laboratories China Co Ltd (6127) pay dividends?
Yes. Joinn Laboratories China Co Ltd pays annual dividends with an annualized yield of 0.65% and an estimated annual payout of HK$0.14 per share.
When is the next ex-dividend date for Joinn Laboratories China Co Ltd (6127)?
The next ex-dividend date is scheduled for June 22, 2027.
What is Joinn Laboratories China Co Ltd (6127) beta (volatility) score?
Joinn Laboratories China Co Ltd has a beta of 0.815, meaning its volatility is roughly in line with the market.